Current FDA-approved GLP-1 drugs available on the market include: Byetta (exenatide) Foundayo (orforglipron) Trulicity (dulaglutide), Victoza, Saxenda, Xultophy (liraglutide) Ozempic, Rybelsus, Wegovy (semaglutide) Mounjaro, Zepbound (tirzepatide) While all GLP-1 drugs can cause weight loss as a side effect, only Wegovy, Saxenda, Foundayo, and Zepbound are FDA approved for weight loss
Begun on one of the first GPL1 drugs
Nitric oxide regulates endotoxin-induced TNF-alpha production by human neutrophils
Adverse reactions led to treatment discontinuation in 6.8% of patients treated with WEGOVY 25 mg tablet and 5.9% patients receiving placebo
Participation in Collaborative Projects: Takeda
Our experienced medical team ensures high-quality home healthcare treatments tailored to your needs .